# A Cross Over Pilot Study of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor

> **NCT03136341** · PHASE4 · RECRUITING · sponsor: **David M. Simpson** · enrollment: 25 (estimated)

## Conditions studied

- Tremor, Limb

## Interventions

- **DRUG:** Abobotulinum toxin A
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03136341
- **Lead sponsor:** David M. Simpson
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-12-04
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2021-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03136341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03136341, "A Cross Over Pilot Study of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03136341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*